We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+18.4%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.28B
AUM Growth
+$253M
Cap. Flow
+$143M
Cap. Flow %
11.17%
Top 10 Hldgs %
13.47%
Holding
1,446
New
471
Increased
321
Reduced
302
Closed
327

Top Buys

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$16.8M
2
U icon
Unity
U
+$14M
3
AIFC
AI Financial Corp
AIFC
+$13.8M
4
CYBR
CyberArk
CYBR
+$12.6M
5
NSC icon
Norfolk Southern
NSC
+$11.7M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$13.2M
2
TSLA icon
Tesla
TSLA
+$12.9M
3
BIDU icon
Baidu
BIDU
+$11.9M
4
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$10M
5
AMED
Amedisys
AMED
+$8.89M

Sector Composition

Rank Sector Weight
1 Technology 21.32%
2 Communication Services 11.38%
3 Healthcare 11.08%
4 Consumer Discretionary 10.37%
5 Financials 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CFSB
426
DELISTED
CFSB Bancorp
CFSB
$664K 0.05%
46,773
+10,990
+31% +$153K
SSRM icon
427
SSR Mining
SSRM
$6.42B
$660K 0.05%
27,033
+13,305
+97% +$225K
CTMX icon
428
CytomX Therapeutics
CTMX
$743M
$659K 0.05%
+206,526
New +$465K
TRMD icon
429
TORM
TRMD
$3.02B
$657K 0.05%
+31,882
New +$642K
WPM icon
430
Wheaton Precious Metals
WPM
$59.5B
$651K 0.05%
+5,823
New +$569K
FWRG icon
431
First Watch Restaurant Group
FWRG
$745M
$649K 0.05%
41,466
+21,653
+109% +$377K
GDS icon
432
GDS Holdings
GDS
$6.31B
$648K 0.05%
16,752
+6,752
+68% +$239K
CNTA
433
DELISTED
Centessa Pharmaceuticals
CNTA
$646K 0.05%
26,656
-23,444
-47% -$417K
AA icon
434
Alcoa
AA
$13.6B
$646K 0.05%
19,633
+2,855
+17% +$88.8K
REG icon
435
Regency Centers
REG
$13.9B
$642K 0.05%
8,802
-9,265
-51% -$661K
COF icon
436
Capital One
COF
$133B
$633K 0.05%
2,977
+1,908
+178% +$418K
FN icon
437
Fabrinet
FN
$19.9B
$631K 0.05%
+1,731
New +$570K
AHL
438
DELISTED
Aspen Insurance
AHL
$630K 0.05%
+17,164
New +$564K
DAY
439
DELISTED
Dayforce
DAY
$619K 0.05%
+8,980
New +$559K
COKE icon
440
Coca-Cola Consolidated
COKE
$12.7B
$618K 0.05%
5,273
-958
-15% -$111K
LFMD icon
441
LifeMD
LFMD
$170M
$617K 0.05%
+90,813
New +$750K
RGLD icon
442
Royal Gold
RGLD
$19.6B
$615K 0.05%
3,066
-445
-13% -$77K
EME icon
443
Emcor
EME
$36.2B
$609K 0.05%
938
-489
-34% -$297K
TOST icon
444
Toast
TOST
$20.3B
$609K 0.05%
+16,681
New +$724K
NN icon
445
NextNav
NN
$2.17B
$607K 0.05%
42,473
+5,868
+16% +$92.6K
WKC icon
446
World Kinect Corp
WKC
$1.89B
$607K 0.05%
23,401
+13,149
+128% +$354K
CHRD icon
447
Chord Energy
CHRD
$7.67B
$606K 0.05%
+6,098
New +$641K
ERIE icon
448
Erie Indemnity
ERIE
$13B
$601K 0.05%
+1,890
New +$653K
MTCH icon
449
Match Group
MTCH
$8.52B
$600K 0.05%
16,978
-31,593
-65% -$1.13M
ALIT icon
450
Alight
ALIT
$405M
$598K 0.05%
+9,169
New +$810K
16 17
18
19 20

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Prelude Capital Management held 1,446 positions worth $1.28B, up 25% from $1.03B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Prelude Capital Management deployed $143M of net new capital in Q3 2025, opening 471 new positions and adding to 321 existing holdings. Its largest new stake was Verona Pharma: 160,565 shares worth $17.1M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $13.2M trimmed.

  • Prelude Capital Management's largest Q3 2025 buy was Verona Pharma: 160,565 shares worth $17.1M.
  • Prelude Capital Management added most to Amazon in Q3 2025, an estimated $11.4M increase.
  • Prelude Capital Management's biggest Q3 2025 reduction was Meta Platforms (Facebook), cutting an estimated $13.2M.
  • Prelude Capital Management fully exited Amedisys in Q3 2025, selling an estimated $8.89M.
  • Prelude Capital Management's ten largest holdings make up 13% of its $1.28B portfolio in Q3 2025.
  • Prelude Capital Management opened 471 new positions and closed 327 in Q3 2025.
  • Prelude Capital Management's portfolio value rose 25% quarter-over-quarter to $1.28B.

Based on Prelude Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.